Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Simona Nicoleta Duna"'
Autor:
Simona Rizea-Savu, Simona Nicoleta Duna, Dimitrios Panagiotopoulos, Roxana Colette Sandulovici
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Lisdexamfetamine is an inactive prodrug of dexamfetamine that is used for the second-line treatment of attention-deficit/hyperactivity disorder (ADHD) and moderate to severe binge eating disorder (BED). Once in the blood, the prodrug is hydrolyzed in
Externí odkaz:
https://doaj.org/article/2cb8f0bd7e0041d5b8b1b064a758ea61
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2021)
Alverine citrate is a spasmolytic commonly prescribed in conditions such as irritable bowel syndrome, painful diverticular disease of the colon, and primary dysmenorrhea. While clinical efficacy data on alverine alone or in combination with simethico
Externí odkaz:
https://doaj.org/article/1a2ce5b636e8447f99f089ef11341280
Publikováno v:
Clinical Pharmacology in Drug Development
Duloxetine is a combined serotonin and norepinephrine reuptake inhibitor indicated in adults for the treatment of major depressive disorder, diabetic peripheral neuropathic pain, and generalized anxiety disorder. The aim of these studies was to evalu
Publikováno v:
Frontiers in Pharmacology
Frontiers in Pharmacology, Vol 11 (2021)
Frontiers in Pharmacology, Vol 11 (2021)
Alverine citrate is a spasmolytic commonly prescribed in conditions such as irritable bowel syndrome, painful diverticular disease of the colon, and primary dysmenorrhea. While clinical efficacy data on alverine alone or in combination with simethico
Autor:
Lucija Vuletić, Marina Herceg, Kristina Ferderber, Jelena Filipović-Grčić, Biserka Cetina-Čižmek, Simona Rizea-Savu, Iva Tunjić, Simona Nicoleta Duna
The rate and extent of absorption of drugs belonging to Biopharmaceutics Classification System class II are rate-limited by dissolution and highly dependent on the performance of the formulated product. The purpose of the present study was to investi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b47d18783183fccaeb0100f1d603c8cc
https://www.bib.irb.hr/1272999
https://www.bib.irb.hr/1272999
Autor:
Adrian Ghita, Simona Nicoleta Duna, Simona Rizea-Savu, David Puibert, Adelina Ciuciuleaca, Irene Manzanera
Publikováno v:
Journal of Bioequivalence & Bioavailability. 11
The bioavailability of an active substance might be altered when a solid oral dosage form (SODF) is crushed or disintegrated and mixed with fluids or food in order to assist swallowing. In consequence, the current European Medicines Agency (EMA) prac